Home » Australia's Clinuvel Pharma Wins FDA Approval for its Drug
Australia's Clinuvel Pharma Wins FDA Approval for its Drug
Clinuvel Pharmaceuticals has been granted orphan-drug status for the first time by the US Food and Drug Administration (FDA) for its drug to treat erythropoietic porphyrias.
TradingMarkets.com
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May